logo

For the Inventor, By the Inventor

Guilford, CT, United States of America

Bonnie Gould-Rothberg

This inventor holds 5 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Curagen Corporation, Celldex Therapeutics Limited. Active years: 2002-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bonnie Gould-Rothberg. Retrieved from https://idiyas.com/inventor/bonnie-gould-rothberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 80.0


Average Co-Inventor Count = 1.3

ph-index = 2

Forward Citations = 37(Granted Patents)


Location History:

  • New Haven, CT (US) (2003)
  • Guilford, CT (US) (2002 - 2015)

Company Filing History:

goldMedal4 out of 84 
 
Curagen Corporation
 patents
silverMedal1 out of 45 
 
Celldex Therapeutics Limited
 patents

Years Active: 2002-2015

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents
1. 9051615 - Method of detecting and treating tuberous sclerosis complex associated disorders (2015-06-09),
2. 6750012 - Method of identifying a psychotropic agent using differential gene expression (2004-06-15),
3. 6620615 - G-protein coupled receptor—encoding nucleic acids (2003-09-16),
4. 6551812 - Compositions and methods relating to the peroxisomal proliferator activated receptor-&agr; mediated pathway (2003-04-22),
5. 6436642 - Method of classifying a thyroid carcinoma using differential gene expression (2002-08-20),

Title: The Innovative Contributions of Bonnie Gould-Rothberg

Introduction

Bonnie Gould-Rothberg is a notable inventor based in Guilford, CT (US). She has made significant contributions to the field of medical research, particularly in the detection and treatment of complex disorders. With a total of 5 patents to her name, her work has had a meaningful impact on healthcare.

Latest Patents

Among her latest patents is a method for detecting and treating tuberous sclerosis complex associated disorders. This patent discloses innovative methods for identifying agents that can effectively treat these disorders. Another significant patent involves the identification of psychotropic agents using differential gene expression. This method aims to find psychotropic agents that do not induce motor side effects, along with novel nucleic acid sequences that are differentially regulated by these agents.

Career Highlights

Throughout her career, Bonnie has worked with prominent companies such as Curagen Corporation and Celldex Therapeutics Limited. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in medical science.

Collaborations

Bonnie has collaborated with talented individuals in her field, including Luca Rastelli and Ryan Murphey. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Bonnie Gould-Rothberg's contributions to medical research and her innovative patents highlight her role as a leading inventor in her field. Her work continues to inspire advancements in the detection and treatment of complex disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…